- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Fine-Tuning Your Multichannel Marketing Strategy
In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic.
In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic, and a similar level of coordination is needed to ensure multichannel success.
Then, there’s the added challenge of managing interactions with today’s multifaceted customer, who could be a government agent; payer; physician (primary, specialist, or key opinion leader); nurse; hospital administrator; or Considering all the complexity in today’s life sciences industry, hitting the right note is much more difficult than just communicating through all channels. It requires a tremendous amount of coordination between sales, marketing and medical affairs.
In this article, Jan van den Burg looks at what companies need to do to execute a multichannel strategy that’s always in tune with the customer.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
